AEE788

DRUG3 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Brain and Central Nervous System TumorsCancerGlioblastoma Multiforme

Phase 1

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

CompletedNCT00107237

Novartis PharmaceuticalsBrain and Central Nervous System Tumors

Start: 2003-10-31End: 2006-06-30Updated: 2013-06-12

Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)

CompletedNCT00116376

Novartis PharmaceuticalsGlioblastoma Multiforme

Start: 2004-01-31End: 2005-11-30Updated: 2015-11-10

Study of Oral AEE788 in Adults With Advanced Cancer

CompletedNCT00118456

Novartis PharmaceuticalsCancer

Start: 2003-07-31Updated: 2012-01-09